Petroleo Brasileiro SA Petrobras
PBR
Adobe
ADBE
MARA Holdings
MARA
4
Salesforce
CRM
5
Vale SA
VALE
US Stock MarketDetailed Quotes
BCLI Brainstorm Cell Therapeutics
- 1.210
- -0.060-4.72%
Close May 6 16:00 ET
7.89MMarket Cap-0.52P/E (TTM)
1.270High1.180Low141.41KVolume1.270Open1.270Pre Close173.61KTurnover2.55%Turnover RatioLossP/E (Static)6.52MShares10.04952wk High-1.02P/B6.72MFloat Cap0.72352wk Low--Dividend TTM5.55MShs Float787.500Historical High--Div YieldTTM7.09%Amplitude0.723Historical Low1.227Avg Price1Lot Size
Brainstorm Cell Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -45.46%11.69M | -33.62%3.19M | -49.49%3.05M | -45.27%2.98M | -51.97%2.47M | -13.63%21.44M | -2.26%4.8M | -11.78%6.04M | -28.22%5.45M | -5.92%5.15M |
| Selling and administrative expenses | -34.14%7.04M | -52.80%1.47M | -25.95%2M | -22.41%2.06M | -32.06%1.51M | -1.59%10.69M | 26.06%3.11M | -11.75%2.71M | 7.14%2.66M | -22.11%2.23M |
| -General and administrative expense | -34.14%7.04M | -52.80%1.47M | -25.95%2M | -22.41%2.06M | -32.06%1.51M | -1.59%10.69M | 26.06%3.11M | -11.75%2.71M | 7.14%2.66M | -22.11%2.23M |
| Research and development costs | -56.72%4.65M | 1.47%1.72M | -68.62%1.05M | -67.00%922K | -67.13%961K | -23.00%10.75M | -30.72%1.7M | -11.81%3.33M | -45.35%2.79M | 11.77%2.92M |
| Operating profit | 45.46%-11.69M | 33.62%-3.19M | 49.49%-3.05M | 45.27%-2.98M | 51.97%-2.47M | 13.63%-21.44M | 2.26%-4.8M | 11.78%-6.04M | 28.22%-5.45M | 5.92%-5.15M |
| Net non-operating interest income expense | 82.77%-77K | 87.73%-66K | 55.37%-54K | -75.00%30K | -85.87%13K | -182.02%-447K | -422.33%-538K | -611.76%-121K | -78.18%120K | -20.00%92K |
| Non-operating interest income | ---- | ---- | ---- | -75.00%30K | -85.87%13K | ---- | ---- | ---- | --120K | -20.00%92K |
| Total other finance cost | -82.77%77K | -87.73%66K | -55.37%54K | ---- | ---- | 182.02%447K | 422.33%538K | 611.76%121K | ---- | ---- |
| Other net income (expense) | -96.87%147K | 219.49%282K | -92.01%394K | 411K | -940K | 4.69M | -236K | 4.93M | ||
| Gain on sale of security | -96.87%147K | 219.49%282K | -92.01%394K | --411K | ---940K | --4.69M | ---236K | --4.93M | ---- | ---- |
| Income before tax | 32.39%-11.62M | 46.70%-2.97M | -120.88%-2.71M | 52.32%-2.54M | 32.77%-3.4M | 29.18%-17.19M | -11.16%-5.58M | 82.12%-1.23M | 24.31%-5.33M | 5.62%-5.06M |
| Income tax | ||||||||||
| Net income | 32.39%-11.62M | 46.70%-2.97M | -120.88%-2.71M | 52.32%-2.54M | 32.77%-3.4M | 29.18%-17.19M | -11.16%-5.58M | 82.12%-1.23M | 24.31%-5.33M | 5.62%-5.06M |
| Net income continuous Operations | 32.39%-11.62M | 46.70%-2.97M | -120.88%-2.71M | 52.32%-2.54M | 32.77%-3.4M | 29.18%-17.19M | -11.16%-5.58M | 82.12%-1.23M | 24.31%-5.33M | 5.62%-5.06M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 32.39%-11.62M | 46.70%-2.97M | -120.88%-2.71M | 52.32%-2.54M | 32.77%-3.4M | 29.18%-17.19M | -11.16%-5.58M | 82.12%-1.23M | 24.31%-5.33M | 5.62%-5.06M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 32.39%-11.62M | 46.70%-2.97M | -120.88%-2.71M | 52.32%-2.54M | 32.77%-3.4M | 29.18%-17.19M | -11.16%-5.58M | 82.12%-1.23M | 24.31%-5.33M | 5.62%-5.06M |
| Basic earnings per share | 61.50%-2.31 | 69.09%-0.51 | -13.33%-0.51 | 69.23%-0.6 | 64.29%-0.75 | 39.39%-6 | 15.38%-1.65 | 84.21%-0.45 | 31.58%-1.95 | 6.67%-2.1 |
| Diluted earnings per share | 61.50%-2.31 | 69.09%-0.51 | -13.33%-0.51 | 69.23%-0.6 | 64.29%-0.75 | 39.39%-6 | 15.38%-1.65 | 84.21%-0.45 | 31.58%-1.95 | 6.67%-2.1 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀